GlassScriptPhysician profile
Jared S Cohen
NPI 1639598279
$10,649.34
in general payments reported to CMS, 2019-2025
44 companies · $1,685 in 2025
The $1,685 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $78.70 · 2021: $1,585 · 2022: $1,573 · 2023: $2,162 · 2024: $3,338 · 2025: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,679 · Travel and Lodging: $2,015 · Education: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,678.50 |
| Travel and Lodging | $2,015.48 |
| Education | $491.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,779.43 | 2020-2025 | Ams 700, Axonics, Rezum Generator |
| Astellas Pharma US INC | $1,275.46 | 2019-2025 | Xtandi, Myrbetriq |
| Axonics, INC. | $1,194.27 | 2021-2024 | Axonics |
| Endo Pharmaceuticals INC. | $392.80 | 2021-2024 | Xiaflex, Aveed, Edex |
| Procept Biorobotics Corporation | $336.26 | 2021-2024 | Aquabeam System, Aquabeam Robotic System |
| Endo USA, INC. | $279.18 | 2024-2025 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $257.93 | 2024-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $254.61 | 2023-2025 | Prolaris, Myrisk |
| Sumitomo Pharma America, INC. | $221.03 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $211.82 | 2021-2025 | |
| Tolmar, INC. | $210.10 | 2023-2025 | Jatenzo, Eligard |
| Coloplast Corp | $203.50 | 2019-2023 | Speedicath |
| Antares Pharma, INC. | $202.17 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Myovant Sciences INC. | $176.18 | 2021-2022 | |
| Abbvie INC. | $170.95 | 2021-2024 | Lupron Depot |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.